MDB Stock Overview
Medicofarma Biotech SA, a biotechnology company, provides medicines, medicinal products, and biotechnology products.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Medicofarma Biotech SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł0.93 |
52 Week High | zł2.00 |
52 Week Low | zł0.83 |
Beta | 3.16 |
1 Month Change | -2.32% |
3 Month Change | -11.20% |
1 Year Change | -14.47% |
3 Year Change | -72.30% |
5 Year Change | 107.14% |
Change since IPO | -28.62% |
Recent News & Updates
Recent updates
Shareholder Returns
MDB | PL Life Sciences | PL Market | |
---|---|---|---|
7D | -0.2% | -2.2% | -0.7% |
1Y | -14.5% | -6.6% | 24.7% |
Return vs Industry: MDB underperformed the Polish Life Sciences industry which returned -6.6% over the past year.
Return vs Market: MDB underperformed the Polish Market which returned 24.7% over the past year.
Price Volatility
MDB volatility | |
---|---|
MDB Average Weekly Movement | 4.1% |
Life Sciences Industry Average Movement | 6.1% |
Market Average Movement | 5.0% |
10% most volatile stocks in PL Market | 9.7% |
10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: MDB has not had significant price volatility in the past 3 months.
Volatility Over Time: MDB's weekly volatility has decreased from 10% to 4% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 20 | Cezary Kilczewski | medicofarmabiotech.pl |
Medicofarma Biotech SA, a biotechnology company, provides medicines, medicinal products, and biotechnology products. The company is involved in the research and development works in collaboration with pharmaceutical and cosmetic manufacturing plants, as well as research units. It also offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics; and covid-19 test kits, such as real time PCR genetic tests.
Medicofarma Biotech SA Fundamentals Summary
MDB fundamental statistics | |
---|---|
Market cap | zł63.08m |
Earnings (TTM) | -zł2.67m |
Revenue (TTM) | zł750.81k |
84.0x
P/S Ratio-23.6x
P/E RatioIs MDB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDB income statement (TTM) | |
---|---|
Revenue | zł750.81k |
Cost of Revenue | zł914.82k |
Gross Profit | -zł164.01k |
Other Expenses | zł2.51m |
Earnings | -zł2.67m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
Earnings per share (EPS) | -0.039 |
Gross Margin | -21.84% |
Net Profit Margin | -355.88% |
Debt/Equity Ratio | 0% |
How did MDB perform over the long term?
See historical performance and comparison